Tiansheng Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of December 2023: -3.12%

Tiansheng Pharmaceutical Group Co Ltd (002872) has an Asset Resilience Ratio of -3.12% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥-87.67 Million
≈ $-12.83 Million USD Cash + Short-term Investments

Total Assets

CN¥2.81 Billion
≈ $411.32 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2023)

This chart shows how Tiansheng Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Tiansheng Pharmaceutical Group Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Tiansheng Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tiansheng Pharmaceutical Group Co Ltd market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥-87.67 Million -3.12%
Total Liquid Assets CN¥-87.67 Million -3.12%

Asset Resilience Insights

  • Limited Liquidity: Tiansheng Pharmaceutical Group Co Ltd maintains only -3.12% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Tiansheng Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tiansheng Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Tubize-Fin
BR:TUB
Biotechnology 0.05%
Verona Pharma plc
F:I9SA
Biotechnology 0.00%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Biotechnology 46.79%
Neuren Pharmaceuticals Ltd
AU:NEU
Biotechnology 90.43%
Vor Biopharma Inc
NASDAQ:VOR
Biotechnology 63.47%
Chengdu Kanghua Biological Products
SHE:300841
Biotechnology 1.19%
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488
Biotechnology 4.35%

Annual Asset Resilience Ratio for Tiansheng Pharmaceutical Group Co Ltd (2012–2023)

The table below shows the annual Asset Resilience Ratio data for Tiansheng Pharmaceutical Group Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 -3.12% CN¥-87.67 Million
≈ $-12.83 Million
CN¥2.81 Billion
≈ $411.32 Million
-0.82pp
2022-12-31 -2.30% CN¥-68.30 Million
≈ $-9.99 Million
CN¥2.97 Billion
≈ $434.58 Million
-4.93pp
2021-12-31 2.63% CN¥82.00 Million
≈ $12.00 Million
CN¥3.12 Billion
≈ $456.56 Million
+4.07pp
2020-12-31 -1.45% CN¥-52.69 Million
≈ $-7.71 Million
CN¥3.65 Billion
≈ $533.52 Million
-0.19pp
2019-12-31 -1.26% CN¥-55.16 Million
≈ $-8.07 Million
CN¥4.39 Billion
≈ $642.61 Million
-1.45pp
2018-12-31 0.19% CN¥8.96 Million
≈ $1.31 Million
CN¥4.67 Billion
≈ $683.93 Million
+1.28pp
2016-12-31 -1.09% CN¥-37.04 Million
≈ $-5.42 Million
CN¥3.39 Billion
≈ $496.35 Million
+0.36pp
2015-12-31 -1.45% CN¥-41.56 Million
≈ $-6.08 Million
CN¥2.87 Billion
≈ $419.40 Million
-0.66pp
2014-12-31 -0.79% CN¥-19.60 Million
≈ $-2.87 Million
CN¥2.50 Billion
≈ $365.12 Million
-0.38pp
2013-12-31 -0.41% CN¥-8.82 Million
≈ $-1.29 Million
CN¥2.16 Billion
≈ $315.92 Million
-0.08pp
2012-12-31 -0.33% CN¥-5.70 Million
≈ $-834.25K
CN¥1.74 Billion
≈ $255.19 Million
--
pp = percentage points

About Tiansheng Pharmaceutical Group Co Ltd

SHE:002872 China Biotechnology
Market Cap
$234.99 Million
CN¥1.61 Billion CNY
Market Cap Rank
#15894 Global
#4599 in China
Share Price
CN¥5.05
Change (1 day)
+2.02%
52-Week Range
CN¥4.47 - CN¥5.70
All Time High
CN¥32.59
About

Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, gynecological, orthopedic, cardiology, diabetes, anesthetic, and others. It also provides traditional Chinese medicines and glucose injection. The company was founded in… Read more